Impairment Testing
The McLean Group’s Valuation Advisory practice performs goodwill impairment testing and long-lived asset impairment testing analyses in accordance with ASC 350 & 360. Our team has worked with hundreds of private-held and publicly traded companies to assist in their annual impairment tests. In addition, as noted in Account Standards Update (ASU) 350, goodwill of a reporting unit should be tested between annual tests “if an event occurs, or circumstances change, that would more likely than not reduce the fair value of a reporting unit below its carrying amount”. Examples of such events and circumstances from ASU 350 include the following:
- Macroeconomic conditions such as a deterioration in general economic conditions, limitations on accessing capital, fluctuations in foreign exchange rates, or other developments in equity and credit markets
- Industry and market considerations such as a deterioration in the environment in which an entity operates, an increased competitive environment, a decline in market-dependent multiples or metrics (consider in both absolute terms and relative to peers), a change in the market for an entity’s products or services, or a regulatory or political development
- Cost factors such as increases in raw materials, labor, or other costs that have a negative effect on earnings and cash flows
- Overall financial performance such as negative or declining cash flows or a decline in actual or planned revenue or earnings compared with actual and projected results of relevant prior periods
- Other relevant entity-specific events such as changes in management, key personnel, strategy, or customers; contemplation of bankruptcy; or litigation
- Events affecting a reporting unit such as a change in the composition or carrying amount of its net assets, a more-likely-than-not expectation of selling or disposing all, or a portion, of a reporting unit, the testing for recoverability of a significant asset group within a reporting unit, or recognition of a goodwill impairment loss in the financial statements of a subsidiary that is a component of a reporting unit
- If applicable, a sustained decrease in share price (consider in both absolute terms and relative to peers).
Team Leaders
Ryan Berry
Ryan Berry is a Managing Director at The McLean Group and heads up the firm’s Valuation Advisory practice. Ryan has over 20 years of financial and accounting experience and has performed and overseen thousands of valuation engagements. During the course of his career, he has advised clients on valuations leading up to their IPO, provided fairness and solvency opinions for M&A transactions and recapitalizations, and worked with clients and their auditors on valuations for financial reporting purposes such as purchase price allocations, impairment testing, and complex security valuations. Ryan has also written and contributed to numerous articles on valuation topics and spoken at various conferences and webinars.
Ryan started his career as a financial analyst at Booz Allen Hamilton. While at Booz, Ryan maintained a TS/SCI clearance and worked in both the DoD and Intelligence Agency divisions where he provided financial and operational support to program managers overseeing several mission critical contracts.
Ryan earned a BA in Economics with a minor in Technology, Management, and Policy from the University of Virginia. He also received an MBA from Johns Hopkins University’s Carey School of Business. He’s a CPA accredited in business valuation and a certified valuation analyst through NACVA.
Professional Credentials
- CPA (Virginia)
- Accredited in Business Valuation (ABV) through the AICPA
- Certified Valuation Analyst (CVA) through NACVA
Professional Memberships
- American Institute of CPAs (AICPA)
- National Association of Certified Valuation Analysts (NACVA)
Ryan Berry
Managing Director
Business Valuation Services
Scott Sievers
Mr. Sievers is a Managing Director with The McLean Group’s Valuation Services Group. As a Managing Director within the firm’s business valuation practice, he ensures the completion of business valuations for public and private companies for transaction, financial reporting, equity incentive plan, tax, and other purposes.
Since joining the firm, Mr. Sievers has completed over 1000 valuation engagements, which include business valuations, fairness opinions, solvency opinions, portfolio valuations, purchase price allocations, goodwill impairment tests, long-lived intangible asset tests, and equity incentive plan analyses.
Mr. Sievers is one of the leaders of the firm’s ESOP Practice. In addition to attending several ESOP training seminars and conferences, he has completed the full spectrum of ESOP-related valuation engagements ranging from transaction advisory, fairness opinions, feasibility analyses, annual valuations, and solvency opinions. Moreover, Mr. Sievers has the relevant experience dealing with complex ESOP-specific topics, such as transaction structuring, Fair Market Value of debt, repurchase obligations, follow-on transactions, and minority interest discounts.
He is also one of the leaders of the firm’s valuation analytics team, which specializes in valuing complex derivatives typically through applying option-pricing models, binomial lattice models, or Monte Carlo simulations to comply with IRC 409A, ASC 718, ASC 805, and ASC 815 reporting purposes.
Professional Credentials
- CPA (Virginia)
- Accredited in Business Valuation (ABV) through the AICPA
- Certified Valuation Analyst (CVA) through NACVA
Scott Sievers
Managing Director
Business Valuation Services
Shari Overstreet
Ms. Overstreet has 30 years of financial, accounting, business valuation and mergers and acquisitions experience. She holds a CPA and FINRA investment banking licenses, as well as a variety of business valuation, and merger and acquisitions-related designations. During her career, Ms. Overstreet worked for a large national accounting firm as an auditor and tax professional. She also was a Controller, Director of Finance, and Chief Financial Officer for privately-held and publicly-traded companies ranging from small start-ups to companies with annual revenues of $1 billion.
Ms. Overstreet is a principal in and lead’s the firm’s Austin, Texas business valuation practice. She also serves as an investment banker, focused on the healthcare and technology sectors. In this capacity, she works with a vast array of clients and business owners on complex transactions.
Ms. Overstreet is an author and speaker on various mergers and acquisitions, capital formation and business valuation topics. She was a 2010 nominee for the Profiles in Power & Women of Influence of Central Texas Award. She holds a BBA with a finance concentration from the University of Texas at Austin. She previously served on the Advisory Board for the Center for Global Business at McCombs School of Business at the University of Texas at Austin.
Professional Credentials
- FINRA Registered Representative (Series 63 & 79)
- CPA (Texas)
- Accredited in Business Valuation (ABV) through AICPA
- Certified Valuation Analyst (CVA) through NACVA
- Certified M&A Advisor (CM&AA) through the Alliance of M&A Advisors
Professional Memberships
- The Texas Society of CPAs
- American Institute of CPAs (AICPA) including Business Valuation and Forensic Litigation Services division (BVFLS)
- Financial Executives International (Austin Chapter)
- Association of Corporate Growth (Central Texas Chapter)
- National Association of Certified Valuation Analysts (NACVA)
Shari Overstreet
Managing Director
M&A and Valuation (Austin)
Representative Engagements
Related News
Monthly Middle Market M&A Insider Report (November 2024)
The M&A Deal Landscape Continues to Roll: Download Our November M&A Insider Report! The McLean Group’s M&A team is thrilled to unveil the November edition of our M&A Insider Report! This month, we dive deep into post-election sentiment in DGI (Defense, Government & Intelligence) dealmaking. Our report leverages the latest data and expert analysis to examine recent high-value government contracts and M&A activity. We analyze how these developments are redefining the competitive landscape and creating new opportunities for investors. […]
McLean Advised Dignari on Sale to Ernst & Young (EY)
The McLean Group advises DIGNARI on its recent sale to Ernst & Young (EY). DIGNARI, which uses a data-driven strategy to advise U.S. government clients, boasts a 300+ strong workforce […]
McLean Advised Emagined Security on its Sale to Neovera a 424 Capital Company
The McLean Group advised Emagined Security on its recent acquisition by Neovera, a 424 Capital portfolio company. Emagined Security is a leading provider of professional services for information security and compliance solutions in highly regulated industries. Together, Neovera and Emagined Security will combine resources and knowledge to tackle the challenges of the ever-evolving cybersecurity landscape and regulatory requirements, especially within the healthcare, financial and government markets. […]